chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Dizziness, Feeling abnormal, Headache
Clinical narrative: lighthead; diarrhea; Nauseous; cold sore; just not feeling good; Itching at injection site; chills; Fever; headache; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), DIZZINESS (lighthead), ORAL HERPES (cold sore), FEELING ABNORMAL (just not feeling good) and INJECTION SITE PRURITUS (Itching at injection site) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0251921A and 0251921A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Surgery (Stomach surgery) in 2017. Concurrent medical conditions included Sulfonamide allergy and Drug allergy. Concomitant products included ESCITALOPRAM from 09-Jan-2020 to 13-Apr-2021 for Depression, VITAMIN D [VITAMIN D NOS] for Vitamin D low.   On 12-Mar-2021 at 1:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (headache). On 13-Apr-2021, the patient experienced CHILLS (chills) and PYREXIA (Fever). On 23-Apr-2021, the patient experienced ORAL HERPES (cold sore), FEELING ABNORMAL (just not feeling good) and INJECTION SITE PRURITUS (Itching at injection site). On 24-Apr-2021, the patient experienced DIARRHOEA (diarrhea) and NAUSEA (Nauseous). On an unknown date, the patient experienced DIZZINESS (lighthead). The patient was treated with ONDANSETRON ongoing since an unknown date for Vomiting, at a dose of 1 mg 1 dose. On 15-Apr-2021, CHILLS (chills), HEADACHE (headache) and PYREXIA (Fever) had resolved. At the time of the report, DIARRHOEA (diarrhea) and NAUSEA (Nauseous) had resolved and DIZZINESS (lighthead), ORAL HERPES (cold sore), FEELING ABNORMAL (just not feeling good) and INJECTION SITE PRURITUS (Itching at injection site) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-057793 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 31-May-2021: Follow up received on 31MAY2021, contains Non significant information.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Nausea, Oral herpes, Pyrexia
Clinical narrative: lighthead; diarrhea; Nauseous; cold sore; just not feeling good; Itching at injection site; chills; Fever; headache; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), DIZZINESS (lighthead), ORAL HERPES (cold sore), FEELING ABNORMAL (just not feeling good) and INJECTION SITE PRURITUS (Itching at injection site) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0251921A and 0251921A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Surgery (Stomach surgery) in 2017. Concurrent medical conditions included Sulfonamide allergy and Drug allergy. Concomitant products included ESCITALOPRAM from 09-Jan-2020 to 13-Apr-2021 for Depression, VITAMIN D [VITAMIN D NOS] for Vitamin D low.   On 12-Mar-2021 at 1:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (headache). On 13-Apr-2021, the patient experienced CHILLS (chills) and PYREXIA (Fever). On 23-Apr-2021, the patient experienced ORAL HERPES (cold sore), FEELING ABNORMAL (just not feeling good) and INJECTION SITE PRURITUS (Itching at injection site). On 24-Apr-2021, the patient experienced DIARRHOEA (diarrhea) and NAUSEA (Nauseous). On an unknown date, the patient experienced DIZZINESS (lighthead). The patient was treated with ONDANSETRON ongoing since an unknown date for Vomiting, at a dose of 1 mg 1 dose. On 15-Apr-2021, CHILLS (chills), HEADACHE (headache) and PYREXIA (Fever) had resolved. At the time of the report, DIARRHOEA (diarrhea) and NAUSEA (Nauseous) had resolved and DIZZINESS (lighthead), ORAL HERPES (cold sore), FEELING ABNORMAL (just not feeling good) and INJECTION SITE PRURITUS (Itching at injection site) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-057793 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 31-May-2021: Follow up received on 31MAY2021, contains Non significant information.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Swelling
Clinical narrative: itching; redness; Swelling; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching), ERYTHEMA (redness) and SWELLING (Swelling) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced PRURITUS (itching), ERYTHEMA (redness) and SWELLING (Swelling). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 26-Feb-2021, PRURITUS (itching), ERYTHEMA (redness) and SWELLING (Swelling) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported.   Most recent FOLLOW-UP information incorporated above includes: On 18-Jul-2021: Follow up received: Contain Non significant information
Sex: M
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Fatigue, Headache, Limb discomfort
Clinical narrative: thirsty; not hungry; sore arm; tiredness (slept alot); headache; light fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of THIRST (thirsty), DECREASED APPETITE (not hungry), LIMB DISCOMFORT (sore arm), FATIGUE (tiredness (slept alot)) and HEADACHE (headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033c21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced THIRST (thirsty), DECREASED APPETITE (not hungry), LIMB DISCOMFORT (sore arm), FATIGUE (tiredness (slept alot)), HEADACHE (headache), PYREXIA (light fever) and CHILLS (chills). At the time of the report, THIRST (thirsty), DECREASED APPETITE (not hungry), LIMB DISCOMFORT (sore arm), FATIGUE (tiredness (slept alot)), HEADACHE (headache), PYREXIA (light fever) and CHILLS (chills) had resolved.            No concomitant medications were reported by the reporter.  No treatment information was reported by the reporter.   This case was linked to MOD-2021-073059 and MOD-2021-124783, MOD-2021-073059 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Followup information was received on 16-Jun-2021 and contains non-significant information. The contact detail was added.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Thirst
Clinical narrative: thirsty; not hungry; sore arm; tiredness (slept alot); headache; light fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of THIRST (thirsty), DECREASED APPETITE (not hungry), LIMB DISCOMFORT (sore arm), FATIGUE (tiredness (slept alot)) and HEADACHE (headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033c21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced THIRST (thirsty), DECREASED APPETITE (not hungry), LIMB DISCOMFORT (sore arm), FATIGUE (tiredness (slept alot)), HEADACHE (headache), PYREXIA (light fever) and CHILLS (chills). At the time of the report, THIRST (thirsty), DECREASED APPETITE (not hungry), LIMB DISCOMFORT (sore arm), FATIGUE (tiredness (slept alot)), HEADACHE (headache), PYREXIA (light fever) and CHILLS (chills) had resolved.            No concomitant medications were reported by the reporter.  No treatment information was reported by the reporter.   This case was linked to MOD-2021-073059 and MOD-2021-124783, MOD-2021-073059 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Followup information was received on 16-Jun-2021 and contains non-significant information. The contact detail was added.
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Tremor
Clinical narrative: The shakes; weakness; chills; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (The shakes), ASTHENIA (weakness) and CHILLS (chills) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TREMOR (The shakes), ASTHENIA (weakness) and CHILLS (chills). At the time of the report, TREMOR (The shakes), ASTHENIA (weakness) and CHILLS (chills) had resolved.            No concomitant medication were reported. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 11-Jun-2021: NNI On 08-Jul-2021: Significant FU: AE outcome updated
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and PYREXIA (Fever) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHILLS (Chills) and PYREXIA (Fever). At the time of the report, CHILLS (Chills) and PYREXIA (Fever) had resolved.            Action taken with mRNA-1273 in response to the events was not applicable.No concomitant medications were reported.No treatment information was provided.    This case was linked to US-MODERNATX, INC.-MOD-2021-060824 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-060824:First dose case
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Fatigue, Memory impairment
Clinical narrative: Stomach upset; Increased forgetfulness; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Stomach upset), MEMORY IMPAIRMENT (Increased forgetfulness) and FATIGUE (Fatigue) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046B21A and 044A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (Stomach upset), MEMORY IMPAIRMENT (Increased forgetfulness) and FATIGUE (Fatigue). At the time of the report, ABDOMINAL DISCOMFORT (Stomach upset), MEMORY IMPAIRMENT (Increased forgetfulness) and FATIGUE (Fatigue) outcome was unknown.            Concomitant medications included unspecified blood pressure medications and vitamin supplements.  No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.    This case was linked to MOD-2021-060898 (Patient Link).
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness at injection site) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032120A) for COVID-19 immunisation.     No past medical history provided.  Concomitant products included ASENAPINE MALEATE (SAPHRIS), ZOLPIDEM TARTRATE (AMBIEN), CARBAMAZEPINE (TEGRETOL), DISULFIRAM (ANTABUSE), VALBENAZINE TOSILATE (INGREZZA), TRAZODONE, CLONIDINE, ACETYLSALICYLIC ACID (ASPRIN) and CHLORPROMAZINE for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (soreness at injection site). At the time of the report, VACCINATION SITE PAIN (soreness at injection site) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.   This case was linked to MOD-2021-122436 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: Non-Significant follow up appended
Sex: U
Vaccine: COVID19
Symptoms: Eye disorder
Clinical narrative: lot of people got problems with their eyes after receiving 2nd dose of moderna vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of EYE DISORDER (lot of people got problems with their eyes after receiving 2nd dose of moderna vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EYE DISORDER (lot of people got problems with their eyes after receiving 2nd dose of moderna vaccine). At the time of the report, EYE DISORDER (lot of people got problems with their eyes after receiving 2nd dose of moderna vaccine) outcome was unknown.            This case was linked to US-MODERNATX, INC.-MOD-2021-118006 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-118006:Case for patient
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: vomiting; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (vomiting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VOMITING (vomiting). The patient was treated with METOCLOPRAMIDE (REGLAN [METOCLOPRAMIDE]) for Vomiting, at an unspecified dose and frequency. At the time of the report, VOMITING (vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications was not provided by the reporter. Treatment information included do not tolerate Zofran.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Somnolence
Clinical narrative: Very sleepy and tired; Very sleepy and tired; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Very sleepy and tired) and FATIGUE (Very sleepy and tired) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (Very sleepy and tired) and FATIGUE (Very sleepy and tired). At the time of the report, SOMNOLENCE (Very sleepy and tired) and FATIGUE (Very sleepy and tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter. The reported stated her husband did well for first 3 weeks before the event began.  No treatment information was provided by the reporter.   This case was linked to MOD-2021-060416 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Cough, Fatigue, Oropharyngeal pain, Rhinorrhoea
Clinical narrative: sore throat; cough; runny and stuffy nose; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), COUGH (cough), RHINORRHOEA (runny and stuffy nose) and FATIGUE (fatigue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (sore throat), COUGH (cough), RHINORRHOEA (runny and stuffy nose) and FATIGUE (fatigue). At the time of the report, OROPHARYNGEAL PAIN (sore throat), COUGH (cough), RHINORRHOEA (runny and stuffy nose) and FATIGUE (fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided. The patient would not be taking the second dose.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Joint swelling, Peripheral swelling, Pruritus
Clinical narrative: Swollen shoulder; Swollen upper arm; Arm hot; Arm itchy; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen upper arm), FEELING HOT (Arm hot), PRURITUS (Arm itchy) and JOINT SWELLING (Swollen shoulder) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A and 024M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  The patient's past medical history included No adverse event (no medical history reported). Concomitant products included SPIRONOLACTONE for an unknown indication.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced PERIPHERAL SWELLING (Swollen upper arm), FEELING HOT (Arm hot) and PRURITUS (Arm itchy). On 07-Apr-2021, the patient experienced JOINT SWELLING (Swollen shoulder). At the time of the report, PERIPHERAL SWELLING (Swollen upper arm), FEELING HOT (Arm hot), PRURITUS (Arm itchy) and JOINT SWELLING (Swollen shoulder) had resolved.      Action taken with mRNA-1273 in response to the events was not Applicable.    This case was linked to MOD-2021-037412 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: bad head pain; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (bad head pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, the patient experienced HEADACHE (bad head pain). On 26-Apr-2021, HEADACHE (bad head pain) had resolved. Not Provided          No relevant concomitant medications were reported. No treatment information was reported.    This case was linked to MOD-2021-061077 (Patient Link).
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling cold
Clinical narrative: feeling cold; relatively mild symptoms of chills; tired; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (feeling cold), CHILLS (relatively mild symptoms of chills) and FATIGUE (tired) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING COLD (feeling cold), CHILLS (relatively mild symptoms of chills) and FATIGUE (tired). At the time of the report, FEELING COLD (feeling cold), CHILLS (relatively mild symptoms of chills) and FATIGUE (tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided.  No treatment medication was provided.   This case was linked to MOD-2021-060668, MOD-2021-125978 (Patient Link).
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: redness at the injection site; soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (redness at the injection site) and INJECTION SITE PAIN (soreness at the injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE ERYTHEMA (redness at the injection site) and INJECTION SITE PAIN (soreness at the injection site). At the time of the report, INJECTION SITE ERYTHEMA (redness at the injection site) and INJECTION SITE PAIN (soreness at the injection site) had resolved.            Action taken with mRNA-1273 in response to the events was not Applicable. No concomitant medications reported by investigator  No treatment medications provided by the reporter.     This case was linked to MOD-2021-061192, MOD-2021-061192 (Patient Link).
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Amnesia, Bedridden, Chills, Cognitive disorder, Fatigue
Clinical narrative: Cognitive loss; Memory problems; Myalgia; Worse fatigue; Nausea; Chills; Bedridden; Weight loss; Sick a month; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHILLS (Chills), FATIGUE (Worse fatigue), NAUSEA (Nausea), COGNITIVE DISORDER (Cognitive loss) and AMNESIA (Memory problems) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 096A21A and 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Chronic fatigue since 1990 and Chronic active Epstein-Barr virus infection since 1990. Concomitant products included SERTRALINE, DOXYCYCLINE and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced ILLNESS (Sick a month). On 24-Mar-2021, the patient experienced CHILLS (Chills), NAUSEA (Nausea), WEIGHT DECREASED (Weight loss) and BEDRIDDEN (Bedridden). On an unknown date, the patient experienced FATIGUE (Worse fatigue), COGNITIVE DISORDER (Cognitive loss), AMNESIA (Memory problems) and PAIN (Aches). In April 2021, ILLNESS (Sick a month) and BEDRIDDEN (Bedridden) had resolved. At the time of the report, CHILLS (Chills), NAUSEA (Nausea), PAIN (Aches) and WEIGHT DECREASED (Weight loss) had resolved and FATIGUE (Worse fatigue), COGNITIVE DISORDER (Cognitive loss) and AMNESIA (Memory problems) had not resolved.            Patient experienced a flu like illness, aches, pain, and was bedridden for three days. Patient experienced weakness, cognitive, and memory problems for over a month after receiving the second dose of the Moderna COVID-19 vaccine.   No treatment medication was provided from the reporter.    Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Followup was received. Updated events, patient details, and vaccine information
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Myalgia, Nausea, Weight decreased
Clinical narrative: Cognitive loss; Memory problems; Myalgia; Worse fatigue; Nausea; Chills; Bedridden; Weight loss; Sick a month; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHILLS (Chills), FATIGUE (Worse fatigue), NAUSEA (Nausea), COGNITIVE DISORDER (Cognitive loss) and AMNESIA (Memory problems) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 096A21A and 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Chronic fatigue since 1990 and Chronic active Epstein-Barr virus infection since 1990. Concomitant products included SERTRALINE, DOXYCYCLINE and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced ILLNESS (Sick a month). On 24-Mar-2021, the patient experienced CHILLS (Chills), NAUSEA (Nausea), WEIGHT DECREASED (Weight loss) and BEDRIDDEN (Bedridden). On an unknown date, the patient experienced FATIGUE (Worse fatigue), COGNITIVE DISORDER (Cognitive loss), AMNESIA (Memory problems) and PAIN (Aches). In April 2021, ILLNESS (Sick a month) and BEDRIDDEN (Bedridden) had resolved. At the time of the report, CHILLS (Chills), NAUSEA (Nausea), PAIN (Aches) and WEIGHT DECREASED (Weight loss) had resolved and FATIGUE (Worse fatigue), COGNITIVE DISORDER (Cognitive loss) and AMNESIA (Memory problems) had not resolved.            Patient experienced a flu like illness, aches, pain, and was bedridden for three days. Patient experienced weakness, cognitive, and memory problems for over a month after receiving the second dose of the Moderna COVID-19 vaccine.   No treatment medication was provided from the reporter.    Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Followup was received. Updated events, patient details, and vaccine information
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: pain on site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain on site of injection) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (pain on site of injection). At the time of the report, VACCINATION SITE PAIN (pain on site of injection) had resolved.            No concomitant medication/lab results were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-062179 (E2B Linked Report). This case was linked to MOD-2021-062348 (Patient Link).
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, SARS-CoV-2 antibody test
Clinical narrative: His second dose of vaccine was pushed out a month as recommended by his doctor; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (His second dose of vaccine was pushed out a month as recommended by his doctor) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (His second dose of vaccine was pushed out a month as recommended by his doctor). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (His second dose of vaccine was pushed out a month as recommended by his doctor) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 antibody test: unknown (Positive) positive.         No concomitant medication was reported. No treatment medications was reported .   This case was linked to MOD-2021-126275 (E2B Linked Report). This case was linked to MOD-2021-054673 (Patient Link).; Sender's Comments:  MOD-2021-126275:Dose 2 case
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Pyrexia
Clinical narrative: Chills; Fatigue; Fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), FATIGUE (Fatigue) and PYREXIA (Fever) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021BZIA and 030AZIA) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Nasal swab) on 26-Nov-2020. Concurrent medical conditions included Drug allergy (Doxycyline, Leviquin) and Food allergy. Concomitant products included SIMVASTATIN and ROSUVASTATIN for High cholesterol, COLECALCIFEROL (D3), MAGNESIUM, ZINC PICOLINATE and CURCUMIN for an unknown indication.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced CHILLS (Chills), FATIGUE (Fatigue) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) for Low grade fever, at an unspecified dose and frequency. At the time of the report, CHILLS (Chills) outcome was unknown and FATIGUE (Fatigue) and PYREXIA (Fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (High) Low grade fever.         This case was linked to MOD-2021-072898 (Patient Link).
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Inappropriate schedule of product administration, Vaccination site pain
Clinical narrative: moved date of second shot to a later date to be safe; two days of pain of the injected arm; one day of mild headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (two days of pain of the injected arm), HEADACHE (one day of mild headache) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (moved date of second shot to a later date to be safe) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039A21A and 012A21A) for COVID-19 vaccination.     The patient's past medical history included Tooth extraction.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (two days of pain of the injected arm), HEADACHE (one day of mild headache) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (moved date of second shot to a later date to be safe). At the time of the report, VACCINATION SITE PAIN (two days of pain of the injected arm) and HEADACHE (one day of mild headache) had resolved and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (moved date of second shot to a later date to be safe) outcome was unknown.            The patient underwent tooth extraction which  caused a severe infection and swelling due to which the patient underwent two oral surgeries and was taking high doses of antibiotics, so moved the date of second shot to a later date for a safer side.   This case was linked to MOD-2021-054492 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: not been feeling well; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (not been feeling well) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On 12-May-2021 at 2:00 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (not been feeling well). At the time of the report, MALAISE (not been feeling well) outcome was unknown.            No concomitant medication details provided.  No Treatment medication details provided.  The reporter reported that the patient have not been feeling well after her second vaccine. she would log in later if she felt better. she will also report her symptoms to the Moderna PV team according to the fact sheet since is the vaccine she received.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dry mouth, Injection site reaction, Insomnia, Pain
Clinical narrative: did not sleep; body aches/Twinge in one side; fever; chills/shivered under the covers all night; Withdrawal from the methadone; Excessive thirst; Mouth was really dry; Injection site reaction characterized by a bit of burning pain in the gluteal muscle; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (did not sleep), PAIN (body aches/Twinge in one side), WITHDRAWAL SYNDROME (Withdrawal from the methadone), THIRST (Excessive thirst) and DRY MOUTH (Mouth was really dry) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product NALTREXONE (VIVITROL) for Opioid type dependence.    The patient's past medical history included Opioid type dependence (Methadone) and Hepatorenal failure.   On 13-Apr-2021, the patient started NALTREXONE (VIVITROL) (unknown route) 380 milligram once a month. On 27-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced WITHDRAWAL SYNDROME (Withdrawal from the methadone), THIRST (Excessive thirst), DRY MOUTH (Mouth was really dry) and INJECTION SITE REACTION (Injection site reaction characterized by a bit of burning pain in the gluteal muscle). On 27-Apr-2021, the patient experienced INSOMNIA (did not sleep), PAIN (body aches/Twinge in one side), PYREXIA (fever) and CHILLS (chills/shivered under the covers all night). At the time of the report, INSOMNIA (did not sleep), INJECTION SITE REACTION (Injection site reaction characterized by a bit of burning pain in the gluteal muscle) and CHILLS (chills/shivered under the covers all night) had resolved and PAIN (body aches/Twinge in one side), WITHDRAWAL SYNDROME (Withdrawal from the methadone), THIRST (Excessive thirst), DRY MOUTH (Mouth was really dry) and PYREXIA (fever) had not resolved.            Treatment information was not provided. No concomitant medications were reported.   On an unknown date, two weeks prior to starting Vivitrol, the patient stopped methadone.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Thirst, Withdrawal syndrome
Clinical narrative: did not sleep; body aches/Twinge in one side; fever; chills/shivered under the covers all night; Withdrawal from the methadone; Excessive thirst; Mouth was really dry; Injection site reaction characterized by a bit of burning pain in the gluteal muscle; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (did not sleep), PAIN (body aches/Twinge in one side), WITHDRAWAL SYNDROME (Withdrawal from the methadone), THIRST (Excessive thirst) and DRY MOUTH (Mouth was really dry) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product NALTREXONE (VIVITROL) for Opioid type dependence.    The patient's past medical history included Opioid type dependence (Methadone) and Hepatorenal failure.   On 13-Apr-2021, the patient started NALTREXONE (VIVITROL) (unknown route) 380 milligram once a month. On 27-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced WITHDRAWAL SYNDROME (Withdrawal from the methadone), THIRST (Excessive thirst), DRY MOUTH (Mouth was really dry) and INJECTION SITE REACTION (Injection site reaction characterized by a bit of burning pain in the gluteal muscle). On 27-Apr-2021, the patient experienced INSOMNIA (did not sleep), PAIN (body aches/Twinge in one side), PYREXIA (fever) and CHILLS (chills/shivered under the covers all night). At the time of the report, INSOMNIA (did not sleep), INJECTION SITE REACTION (Injection site reaction characterized by a bit of burning pain in the gluteal muscle) and CHILLS (chills/shivered under the covers all night) had resolved and PAIN (body aches/Twinge in one side), WITHDRAWAL SYNDROME (Withdrawal from the methadone), THIRST (Excessive thirst), DRY MOUTH (Mouth was really dry) and PYREXIA (fever) had not resolved.            Treatment information was not provided. No concomitant medications were reported.   On an unknown date, two weeks prior to starting Vivitrol, the patient stopped methadone.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Soreness of left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness of left arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis and Asthma. Concomitant products included METHOTREXATE for Rheumatoid arthritis.    On 12-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-May-2021, the patient experienced PAIN IN EXTREMITY (Soreness of left arm). At the time of the report, PAIN IN EXTREMITY (Soreness of left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. Concomitant medications also included an unspecified asthma inhaler.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Flushing, Heart rate, Hypertension
Clinical narrative: rapid heart beat; High blood pressure; flushing; body aches; fever; tired; chills; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (rapid heart beat), HYPERTENSION (High blood pressure), FLUSHING (flushing), PAIN (body aches) and PYREXIA (fever) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008C21A and 038B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high and Anxiety. Concomitant products included CLONIDINE for Blood pressure high and Anxiety, OMEPRAZOLE (PROTONIX [OMEPRAZOLE]), CLONAZEPAM (KLONOPIN), BREXPIPRAZOLE (REXULTI), LISDEXAMFETAMINE MESILATE (VYVANSE), FLUTICASONE FUROATE, VILANTEROL TRIFENATATE (BREO ELLIPTA), MULTIVITAMIN [VITAMINS NOS], MIRTAZAPINE (REMERON), LEVOTHYROXINE SODIUM (LEVOTHYROXINE [LEVOTHYROXINE SODIUM]) and FLUCONAZOLE (DIFLUCAN) for an unknown indication.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-May-2021, the patient experienced TACHYCARDIA (rapid heart beat), HYPERTENSION (High blood pressure), FLUSHING (flushing), PAIN (body aches), PYREXIA (fever), FATIGUE (tired) and CHILLS (chills). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, TACHYCARDIA (rapid heart beat), HYPERTENSION (High blood pressure), FLUSHING (flushing), PAIN (body aches), PYREXIA (fever), FATIGUE (tired) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-May-2021, Heart rate: high (High) Pulse is in the hundreds..         Concomitant medications also included unspecified birth control pills and an unspecified daily probiotic.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Tachycardia
Clinical narrative: rapid heart beat; High blood pressure; flushing; body aches; fever; tired; chills; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (rapid heart beat), HYPERTENSION (High blood pressure), FLUSHING (flushing), PAIN (body aches) and PYREXIA (fever) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008C21A and 038B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high and Anxiety. Concomitant products included CLONIDINE for Blood pressure high and Anxiety, OMEPRAZOLE (PROTONIX [OMEPRAZOLE]), CLONAZEPAM (KLONOPIN), BREXPIPRAZOLE (REXULTI), LISDEXAMFETAMINE MESILATE (VYVANSE), FLUTICASONE FUROATE, VILANTEROL TRIFENATATE (BREO ELLIPTA), MULTIVITAMIN [VITAMINS NOS], MIRTAZAPINE (REMERON), LEVOTHYROXINE SODIUM (LEVOTHYROXINE [LEVOTHYROXINE SODIUM]) and FLUCONAZOLE (DIFLUCAN) for an unknown indication.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-May-2021, the patient experienced TACHYCARDIA (rapid heart beat), HYPERTENSION (High blood pressure), FLUSHING (flushing), PAIN (body aches), PYREXIA (fever), FATIGUE (tired) and CHILLS (chills). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, TACHYCARDIA (rapid heart beat), HYPERTENSION (High blood pressure), FLUSHING (flushing), PAIN (body aches), PYREXIA (fever), FATIGUE (tired) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-May-2021, Heart rate: high (High) Pulse is in the hundreds..         Concomitant medications also included unspecified birth control pills and an unspecified daily probiotic.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Nausea, Pain
Clinical narrative: Fatigue; some swelling between clavicle and neck for first couple days; Intermittent pain which was just uncomfortable/just sore mostly in upper body; Little bit of sore arm; Really bad shoulder pain and joint pain; little bit nausea; little bit chills; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (some swelling between clavicle and neck for first couple days), PAIN (Intermittent pain which was just uncomfortable/just sore mostly in upper body), PAIN IN EXTREMITY (Little bit of sore arm), ARTHRALGIA (Really bad shoulder pain and joint pain) and NAUSEA (little bit nausea) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Breast cancer. Concurrent medical conditions included Anxiety.    On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced SWELLING (some swelling between clavicle and neck for first couple days), PAIN (Intermittent pain which was just uncomfortable/just sore mostly in upper body), PAIN IN EXTREMITY (Little bit of sore arm), ARTHRALGIA (Really bad shoulder pain and joint pain), NAUSEA (little bit nausea) and CHILLS (little bit chills). On an unknown date, the patient experienced FATIGUE (Fatigue). At the time of the report, SWELLING (some swelling between clavicle and neck for first couple days), PAIN (Intermittent pain which was just uncomfortable/just sore mostly in upper body), PAIN IN EXTREMITY (Little bit of sore arm), ARTHRALGIA (Really bad shoulder pain and joint pain), NAUSEA (little bit nausea), CHILLS (little bit chills) and FATIGUE (Fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported No treatment drugs were reported